WATSON LABS TEVA FDA Approval ANDA 204377

ANDA 204377

WATSON LABS TEVA

FDA Drug Application

Application #204377

Application Sponsors

ANDA 204377WATSON LABS TEVA

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORALEQ 30MG BASE0CINACALCET HYDROCHLORIDECINACALCET HYDROCHLORIDE
002TABLET;ORALEQ 60MG BASE0CINACALCET HYDROCHLORIDECINACALCET HYDROCHLORIDE
003TABLET;ORALEQ 90MG BASE0CINACALCET HYDROCHLORIDECINACALCET HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2018-12-27

Submissions Property Types

ORIG1Null29

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204377
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.